Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis

References

• Günther R, Richter N, Sauerbier A, et al. Non-motor symptoms in patients suffering from motor neuron diseases. Front Neurol. 2016;7:117.
   PubMed Web of Science ®Google Scholar
• Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology. Neurology. 2009;73(15):1218–1226.
   PubMed Web of Science ®Google Scholar
• Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1227–1233.
   PubMed Web of Science ®Google Scholar
• Task EFNS. Force on diagnosis and management of amyotrophic lateral sclerosis:, Andersen PM, Abrahams S, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360–375.
   PubMed Web of Science ®Google Scholar
• Van Den Berg LH, Sorenson E, Gronseth G, et al. Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology. 2019;92(14):e1610–e1623.
   PubMed Web of Science ®Google Scholar
• Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83(1):102–108.
   PubMed Web of Science ®Google Scholar
• Montuschi A, Iazzolino B, Calvo A, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg. 2015;86(2):168–173.
   PubMed Web of Science ®Google Scholar
• Abramzon YA, Fratta P, Traynor BJ, et al. The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci. 2020;14:42.
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130–133.
   PubMed Web of Science ®Google Scholar
• Chiò A, Ilardi A, Cammarosano S, et al. Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology. 2012;78(14):1085–1089.
   PubMed Web of Science ®Google Scholar
• Caga J, Hsieh S, Lillo P, et al. The impact of cognitive and behavioral symptoms on ALS patients and their caregivers. Front Neurol. 2019;10:192.
   PubMed Web of Science ®Google Scholar
• Lillo P, Mioshi E, Hodges JR. Caregiver burden in amyotrophic lateral sclerosis is more dependent on patients’ behavioral changes than physical disability: a comparative study. BMC Neurol. 2012;12(1):156.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotrophic Lateral Scler Fronttemporal Degener. 2017;18(3–4):3–4.
   Web of Science ®Google Scholar
• Abrahams S, Newton J, Niven E, et al. Screening for cognition and behaviour changes in ALS. Amyotrophic Lateral Scler Fronttemporal Degener. 2014;15(1–2):9–14.
   PubMed Web of Science ®Google Scholar
• Woolley SC, York MK, Moore DH, et al. Detecting frontotemporal dysfunction in ALS: utility of the ALS cognitive behavioral screen (ALS-CBS™). Amyotroph Lateral Scler. 2010;11(3):303–311.
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699.
   PubMed Web of Science ®Google Scholar
• Mioshi E, Dawson K, Mitchell J, et al. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21(11):1078–1085.
   PubMed Web of Science ®Google Scholar
• Crockford CJ, Kleynhans M, Wilton E, et al. ECAS A-B-C: alternate forms of the Edinburgh Cognitive and Behavioural ALS Screen. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(1–2):57–64.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Leigh PN, Harvey A, et al. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38(6):734–747.
   PubMed Web of Science ®Google Scholar
• Grant DA, Berg ED. Wisconsin card sorting test. Odessa: Psychological Assessment Resources; 1990. Published online.
   Google Scholar
• Delis DC, Kaplan E, Kramer JH. Delis-Kaplan executive function system. Published online. 2001.
   Google Scholar
• Reitan RM, Wolfson D. A selective and critical review of neuropsychological deficits and the frontal lobes. Neuropsychol Rev. 1994;4(3):161–198.
   PubMed Web of Science ®Google Scholar
• Golden CJ, Freshwater SM. Stroop color and word test. Published online. 1978.
   Google Scholar
• Burgess PW, Shallice T. The Hayling and Brixton Tests: manual. 1.Dr. Harcourt Assessment. 2005.
   Google Scholar
• Stone VE, Baron-Cohen S, Knight RT. Frontal lobe contributions to theory of mind. J Cogn Neurosci. 1998;10(5):640–656.
   PubMed Web of Science ®Google Scholar
• Baron-Cohen S, Wheelwright S, Hill J, et al. “Reading the Mind in the Eyes” Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry. 2001;42(2):241–251.
   PubMed Web of Science ®Google Scholar
• Young A, Perrett DI, and Calder A, et al. Facial expressions of emotion: stimuli and Test (FEEST). Published online 2002 [cited Jul 25 2021]. http://www.harcourt-uk.com/product.aspx?skey=2835
   Google Scholar
• Girardi A, MacPherson SE, Abrahams S. Deficits in emotional and social cognition in amyotrophic lateral sclerosis. Neuropsychology. 2011;25(1):53–65.
   PubMed Web of Science ®Google Scholar
• Arcara G, Bambini V. A Test for the Assessment of Pragmatic Abilities and Cognitive Substrates (APACS): normative data and psychometric properties. Front Psychol. 2016;7:70.
   PubMed Web of Science ®Google Scholar
• Nicholas LE, Brookshire RH. A system for quantifying the informativeness and efficiency of the connected speech of adults with aphasia. J Speech Hear Res. 1993;36(2):338–350.
   PubMedGoogle Scholar
• Graves RE, Bezeau SC, Fogarty J, et al. Boston naming test short forms: a comparison of previous forms with new item response theory based forms. J Clin Exp Neuropsychol. 2004;26(7):891–902.
   PubMed Web of Science ®Google Scholar
• Kaplan E, Goodglass H. Weintraub. Boston naming test. 2nd ed. Austin: PRO-ED; 2000. Published online.
   Google Scholar
• Druks J, and Masterson J. An object and action naming battery: manual. Hove UK; Psychology Press; 2000.
   Google Scholar
• Mckenna P, and Warrington EK. Graded Naming Test: manual. Windsor, UK; NFER-Nelson; 1983.
   Google Scholar
• Martin NA, Brownell R. Expressive one-word picture vocabulary test: spanish-bilingual edition. 4th ed. Novato: Academic Therapy Publications; 2011. Published online.
   Google Scholar
• Williams KT. Expressive vocabulary test. 2nd ed. San Antonio:: Pearson; 2007. Published online.
   Google Scholar
• Thompson CK, Weintraub S. Northwestern Naming Battery (NNB). Evanston: Northwestern University; 2014. Published online.
   Google Scholar
• German D, German D. Test of adolescent/adult word finding. 2nd ed. Boston: VA Medical Centre; 2014. Published online.
   Google Scholar
• Howard D, Patterson K. Pyramid and palm trees. Bury St Edmunds. Suffolk: Thames Valley Test Company; 1992. Published online.
   Google Scholar
• Bak TH, Hodges JR. Kissing and dancing—a test to distinguish the lexical and conceptual contributions to noun/verb and action/object dissociation. Preliminary results in patients with frontotemporal dementia. J Neurolinguistics. 2003;16(2–3):169–181.
   Web of Science ®Google Scholar
• Dunn LM, Dunn DM. Peabody picture vocabulary test. 4th ed. San Antonio: Pearson; 2007. Published online.
   Google Scholar
• Thompson CK. Northwestern assessment of verbs and sentences (NAVS). Evanston: Northwestern University; 2012. Published online.
   Google Scholar
• Bishop D. Test for reception of grammar - version 2 (TROG-2). London UK: Pearson Assessment; 2003. Published online.
   Google Scholar
• Weintraub S, Mesulam -M-M, Wieneke C, et al. The northwestern anagram test: measuring sentence production in primary progressive aphasia. Am J Alzheimers Dis Other Demen. 2009;24(5):408–416.
   PubMed Web of Science ®Google Scholar
• Prutting CA, Kirchner DM. A clinical appraisal of the pragmatic aspects of language. J Speech Hear Disord. 1987;52(2):105–119.
   PubMedGoogle Scholar
• Rousseaux M, Delacourt A, and Wyrzykowski N, et al. 2016 . Test Lillois de Communication. Ortho edition. Icbergues. Published online. Available from: https://pepite-depot.univ-lille2.fr/nuxeo/site/esupversions/e8bf0d0a-714d-421b-8855-dfb081fe3987. accessed on July 25, 2021.
   Google Scholar
• Kertesz A. Western Aphasia Battery. New York: Grune and Stratton; 1982. Published online.
   Google Scholar
• Ripich DN, Terrell BY. Patterns of discourse cohesion and coherence in Alzheimer’s disease. J Speech Hear Disord. 1988;53(1):8–15.
   PubMedGoogle Scholar
• Randolph C, Tierney MC, Mohr E, et al. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20(3):310–319.
   PubMed Web of Science ®Google Scholar
• Schmidt M. Rey Auditory Verbal Learning Test. Los Angeles: Western Psychological Services; 1996. Published online.
   Google Scholar
• Delis DC, Kramer JH, Kaplan E, et al. California Verbal Learning Test manual - adult version. second ed. New York: The Psychological Corporation; 2000. Published online.
   Google Scholar
• Wechsler D. Wechsler Memory Scale (WMS-IV): administration and scoring manual. 4th ed. San Antonio: The Psychological Corporation; 2009. Published online.
   Google Scholar
• Wilson B, Greenfield E, Clare L, et al. Rivermead Behavioural Memory Test. Third. (RBMT-3). London UK: Pearson Assessment. Published online; 2008.
   Google Scholar
• Raaphorst J, Beeldman E, Schmand B, et al. The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALS. Neurology. 2012;79(13):1377–1383.
   PubMed Web of Science ®Google Scholar
• Murphy J, Ahmed F, The L-HC. UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(1–2):24–30.
   PubMed Web of Science ®Google Scholar
• Murphy J, Factor-Litvak P, Goetz R, et al. Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. Neurology. 2016;86(9):813–820.
   PubMed Web of Science ®Google Scholar
• Elamin M, Bede P, Byrne S, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology. 2013;80(17):1590–1597.
   PubMed Web of Science ®Google Scholar
• Poletti B, Solca F, Carelli L, et al. Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotrophic Lateral Scler Fronttemporal Degener. 2018;19(5–6):387–395.
   PubMed Web of Science ®Google Scholar
• Kilani M, Micallef J, Soubrouillard C, et al. A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(1):46–54.
   PubMed Web of Science ®Google Scholar
• Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, et al. Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol. 2005;252(7):772–781.
   PubMed Web of Science ®Google Scholar
• Kasper E, Zydatiss K, Schuster C, et al. No change in executive performance in ALS patients: a longitudinal neuropsychological study. Neurodegener Dis. 2016;16(3–4):184–191.
   PubMed Web of Science ®Google Scholar
• Bock M, Duong Y-N, Kim A, et al. Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis. Neurol Clin Pract. 2017;7(6):488–498.
   PubMedGoogle Scholar
• Beeldman E, Govaarts R, de Visser M, et al. Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2020;91(7):779–780.
   PubMed Web of Science ®Google Scholar
• Bersano E, Sarnelli MF, Solara V, et al. Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study. Amyotrophic Lateral Scler Fronttemporal Degener. 2020;21(5–6):373–379.
   PubMed Web of Science ®Google Scholar
• Beswick E, Forbes D, Hassan Z, et al. A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis. J Neurol. Published online June 13. 2021. DOI:https://doi.org/10.1007/s00415-021-10651-1.
   Google Scholar
• Howland RH. Schizophrenia and amyotrophic lateral sclerosis. Compr Psychiatry. 1990;31(4):327–336.
   PubMed Web of Science ®Google Scholar
• Turner MR, Goldacre R, Talbot K, et al. Psychiatric disorders prior to amyotrophic lateral sclerosis. Ann Neurol. 2016;80(6):935–938.
   PubMed Web of Science ®Google Scholar
• Longinetti E, Mariosa D, Larsson H, et al. Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis. Neurology. 2017;89(6):578–585.
   PubMed Web of Science ®Google Scholar
• Hall D, Finger EC. Psychotic symptoms in frontotemporal dementia. Curr Neurol Neurosci Rep. 2015;15(7):46.
   PubMed Web of Science ®Google Scholar
• Devenney EM, Ahmed RM, Halliday G, et al. Psychiatric disorders in C9orf72 kindreds: study of 1,414 family members. Neurology. 2018;91(16):e1498–e1507.
   PubMed Web of Science ®Google Scholar
• Em D, Landin-Romero R, Irish M, et al. The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion. Neuroimage Clin. 2017;13:439–445.
   PubMed Web of Science ®Google Scholar
• Zucchi E, Ticozzi N, Mandrioli J. psychiatric symptoms in amyotrophic lateral sclerosis: beyond a motor neuron disorder. Front Neurosci. 2019;13:175.
   PubMed Web of Science ®Google Scholar
• Wear HJ, Wedderburn CJ, Mioshi E, et al. The Cambridge Behavioural Inventory revised. Dement Neuropsychol. 2008;2(2):102–107.
   PubMedGoogle Scholar
• Bell V, Halligan PW, Ellis HD. The Cardiff Anomalous Perceptions Scale (CAPS): a new validated measure of anomalous perceptual experience. Schizophr Bull. 2006;32(2):366–377.
   PubMed Web of Science ®Google Scholar
• Devenney EM, Tu S, Caga J, et al. Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum. Ann Clin Transl Neurol. 2021. Published online June 22. DOI:https://doi.org/10.1002/acn3.51363.
   Google Scholar
• De Marchi F, Sarnelli MF, Solara V, et al. Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurol Scand. 2019;139(5):438–445.
   PubMed Web of Science ®Google Scholar
• Edge R, Mills R, Tennant A, et al. Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature. J Neurol. 2020;267(3):607–615.
   PubMed Web of Science ®Google Scholar
• Carvalho TL, LMS de A, Cma L, et al. Depression and anxiety in individuals with amyotrophic lateral sclerosis: a systematic review. Trends Psychiatry Psychother. 2016;38(1):1–5.
   PubMedGoogle Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Gibbons CJ, Mills RJ, Thornton EW, et al. Rasch analysis of the hospital anxiety and depression scale (hads) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9(1):82.
   PubMed Web of Science ®Google Scholar
• Grabler MR, Weyen U, Juckel G, et al. Depression in amyotrophic lateral sclerosis patients and their primary caregivers. Front Neurol. 2018;9:(December):1–6.
   PubMed Web of Science ®Google Scholar
• Wei Q, Zheng Z, Guo X, et al. Association between depression and survival in Chinese amyotrophic lateral sclerosis patients. Neurol Sci. 2016;37(4):557–563.
   PubMed Web of Science ®Google Scholar
• Anca M, Sebastian A, Cristina R, et al. Predictors of depression in caucasian patients with amyotrophic lateral sclerosis in Romania. Brain Sci. 2020;10(8):1–13.
   Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.
   PubMed Web of Science ®Google Scholar
• Spielberger CD, Gorsuch, RL, and Lushene, RE. 1970. Manual for the State-Trait Anxietry, Inventory. Polo Alto, CA: Consulting Psychologists Press. Polo Alto, CA: Consulting Psychologists Press.
   Google Scholar
• Vignola A, Guzzo A, Calvo A, et al. Anxiety undermines quality of life in ALS patients and caregivers. Eur J Neurol. 2008;15(11):1231–1236.
   PubMed Web of Science ®Google Scholar
• Siciliano M, Trojano L, Trojsi F, et al. Assessing anxiety and its correlates in amyotrophic lateral sclerosis: the state-trait anxiety inventory. Muscle Nerve. 2019;60(1):47–55.
   PubMed Web of Science ®Google Scholar
• Beswick E, Glasmacher SA, Dakin R, et al. Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocol. BMJ Open. 2021;11:3.
   Web of Science ®Google Scholar
• Kübler A, Winter S, Ludolph AC, et al. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair. 2005;19(3):182–193.
   PubMed Web of Science ®Google Scholar
• Hammer EM, Häcker S, Hautzinger M, et al. Validity of the ALS-Depression-Inventory (ADI-12)- A new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. J Affect Disord. 2008;109(1–2):213–219.
   PubMed Web of Science ®Google Scholar
• Kuzma-Kozakiewicz M, Andersen PM, Ciecwierska K, et al. An observational study on quality of life and preferences to sustain life in locked-in state. Neurology. 2019;93(10):E938–E945.
   PubMed Web of Science ®Google Scholar
• Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther. 1995;33(3):335–343.
   PubMed Web of Science ®Google Scholar
• Caga J, Ramsey E, Hogden A, et al. A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis. Palliative Supportive Care. 2015;13(4):1019–1024.
   PubMed Web of Science ®Google Scholar
• Lillo P, Mioshi E, Zoing MC, et al. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotrophic Lateral Sclerosis. 2011;12(1):45–51.
   PubMed Web of Science ®Google Scholar
• Leigh N, Simpson J, Eccles FJR. Does a lack of social support and perceived stigma influence the relationship between motor neurone disease-related stress and psychological distress? Br J Health Psychol. 2021;26(2):289–306.
   PubMed Web of Science ®Google Scholar
• Verschueren A, Kianimehr G, Belingher C, et al. Wish to die and reasons for living among patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Scler Fronttemporal Degener. 2019;20(1–2):68–73.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Goetz R, Factor-Litvak P, et al. Depression and wish to die in a multicenter cohort of ALS patients. Amyotrophic Lateral Scler Fronttemporal Degener. 2015;16(3–4):265–273.
   PubMed Web of Science ®Google Scholar
• Stutzki R, Weber M, Reiter-Theil S, et al. Attitudes towards hastened death in ALS: a prospective study of patients and family caregivers. Amyotrophic Lateral Scler Fronttemporal Degener. 2014;15(1–2):68–76.
   PubMed Web of Science ®Google Scholar
• Beswick E, Park E, Wong C, et al. A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis. J Neurol. 2020. ( 0123456789). DOI:https://doi.org/10.1007/s00415-020-10203-z
   Google Scholar
• Posner BL. Columbia-Suicide Severity Rating Scale (C-Ssrs): risk Assessment (Lifeline crisis center version). RFMH. 2014;1–2. Published online. Availabe from: https://cssrs.columbia.edu/wp-content/uploads/C-SSRS_Pediatric-SLC_11.14.16.pdf accessed on July 25, 2021.
   Google Scholar
• Mystakidou K, Rosenfeld B, Parpa E, et al. The schedule of attitudes toward hastened death: validation analysis in terminally ill cancer patients. Palliat Support Care. 2004;2(4):395–402.
   PubMedGoogle Scholar
• Rosenfeld B, Breitbart W, Stein K, et al. Measuring desire for death among patients with HIV/AIDS: the schedule of attitudes toward hastened death. Am J Psychiatry. 1999;156(1):94–100.
   PubMed Web of Science ®Google Scholar
• Chiò A, Canosa A, Gallo S, et al. Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol. 2012;19(4):551–555.
   PubMed Web of Science ®Google Scholar
• Kong Z, Chen P, Jiang J, et al. Pain characteristics in amyotrophic lateral sclerosis patients and its impact on quality of life: a prospective observational study in a northern city of China. Ann Palliat Med. 2021;10(2):1668–1674.
   PubMed Web of Science ®Google Scholar
• Handy CR, Krudy C, Boulis N, et al. Pain in amyotrophic lateral sclerosis: a neglected aspect of disease. Neurol Res Int. 2011;2011:403808.
   PubMedGoogle Scholar
• Wicks P. Reassessing received wisdom in ALS–pain is common when studied systematically. Eur J Neurol. 2012;19(4):531–532.
   PubMed Web of Science ®Google Scholar
• Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs. 1988;14(1):9–17.
   PubMedGoogle Scholar
• Ishida N, Hongo S, Kumano A, et al. Relationship between Pain and Functional Status in Patients with Amyotrophic Lateral Sclerosis: a Multicenter Cross-Sectional Study. J Palliat Med. 2018;21(5):588–591.
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. 1994;23(2):129–138.
   PubMedGoogle Scholar
• Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1(3):277–299.
   PubMed Web of Science ®Google Scholar
• Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology. 1997;48(2):332–338.
   PubMed Web of Science ®Google Scholar
• Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the neuropathic pain symptom inventory. Pain. 2004;108(3):248–257.
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Baron R, Gockel U, et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911–1920.
   PubMed Web of Science ®Google Scholar
• Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1–2):29–36.
   PubMed Web of Science ®Google Scholar
• Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524–532.
   Web of Science ®Google Scholar
• Chiò A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurol. 2017;16(2):144–157.
   PubMed Web of Science ®Google Scholar
• Fang T, Jozsa F, Nonmotor A-CA. Symptoms in amyotrophic lateral sclerosis: a systematic review. Int Rev Neurobiol. 2017;134:1409–1441.
   PubMed Web of Science ®Google Scholar
• Lauria G, Faber CG, Merkies ISJ, et al. Diagnosis of neuropathic pain: challenges and possibilities. Expert Opin Med Diagn. 2012;6(2):89–93.
   PubMedGoogle Scholar
• Åkerblom Y, Jakobsson Larsson B, Zetterberg L, et al. The multiple faces of pain in motor neuron disease: a qualitative study to inform pain assessment and pain management. Disabil Rehabil. 2020;42(15):2123–2132.
   PubMed Web of Science ®Google Scholar
• Gicalone AR, Heckman MG, Otto E, et al. Shoulder pain among patients with amyotrophic lateral sclerosis: a case series. Am J Occup Ther. 2019;73(5). 7305345020p1–7305345020p6.
   PubMed Web of Science ®Google Scholar
• Verschueren A, Grapperon A-M, Delmont E, et al. Prevalence of spasticity and spasticity-related pain among patients with Amyotrophic Lateral Sclerosis. Rev Neurol (Paris). 2021;177(6):694–698.
   PubMed Web of Science ®Google Scholar
• Caress JB, Ciarlone SL, Sullivan EA, et al. Natural history of muscle cramps in amyotrophic lateral sclerosis. Muscle Nerve. 2016;53(4):513–517.
   PubMed Web of Science ®Google Scholar
• Wallace VCJ, Ellis CM, Burman R, et al. The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7–8):520–527.
   PubMed Web of Science ®Google Scholar
• Moisset X, Cornut-Chauvinc C, Clavelou P, et al. Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study. Palliat Med. 2016;30(5):486–494.
   PubMed Web of Science ®Google Scholar
• Hurwitz N, Radakovic R, Boyce E, et al., Prevalence of pain in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener. 2021 March 4:1–10. Published online. DOI:https://doi.org/10.1080/21678421.2021.1892765.
   Google Scholar
• Küffner R, Zach N, Norel R, et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat Biotechnol. 2015;33(1):51–57.
   PubMed Web of Science ®Google Scholar
• Pizzimenti A, Aragona M, Onesti E, et al. Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Funct Neurol. 2013;28(2):115–119.
   PubMedGoogle Scholar
• Stephens HE, Lehman E, Raheja D, et al. Pain in amyotrophic lateral sclerosis: patient and physician perspectives and practices. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1–2):21–29.
   PubMed Web of Science ®Google Scholar
• Rivera I, Ajroud-Driss S, Casey P, et al. Prevalence and characteristics of pain in early and late stages of ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(5–6):369–372.
   PubMed Web of Science ®Google Scholar
• Hanisch F, Skudlarek A, Berndt J, et al. Characteristics of pain in amyotrophic lateral sclerosis. Brain Behav. 2015;5(3):e00296.
   PubMed Web of Science ®Google Scholar
• Adelman EE, Albert SM, Rabkin JG, et al. Disparities in perceptions of distress and burden in ALS patients and family caregivers. Neurology. 2004;62(10):1766–1770.
   PubMed Web of Science ®Google Scholar
• Sandstedt P, Littorin S, Johansson S, et al. Contextual factors in patients with amyotrophic lateral sclerosis - a three-year observational study. J Neuromuscul Dis. 2018;5(4):439–449.
   PubMedGoogle Scholar
• Goy ER, Carter J, Ganzini L. Neurologic disease at the end of life: caregiver descriptions of Parkinson disease and amyotrophic lateral sclerosis. J Palliat Med. 2008;11(4):548–554.
   PubMed Web of Science ®Google Scholar
• Veronese S, Valle A, Chiò A, et al. The last months of life of people with amyotrophic lateral sclerosis in mechanical invasive ventilation: a qualitative study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7–8):499–504.
   PubMed Web of Science ®Google Scholar
• Maessen M, Veldink JH, Onwuteaka-Philipsen BD, et al. Euthanasia and physician-assisted suicide in amyotrophic lateral sclerosis: a prospective study. J Neurol. 2014;261(10):1894–1901.
   PubMed Web of Science ®Google Scholar
• Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet. 2004;363(9413):978–988.
   PubMed Web of Science ®Google Scholar
• Ramirez C, Piemonte MEP, Callegaro D, et al. Fatigue in amyotrophic lateral sclerosis: frequency and associated factors. Amyotroph Lateral Scler. 2008;9(2):75–80.
   PubMed Web of Science ®Google Scholar
• McElhiney MC, Rabkin JG, Gordon PH, et al. Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry. 2009;80(10):1146–1149.
   PubMed Web of Science ®Google Scholar
• Panitz S, Kornhuber M, Hanisch F. The checklist individual strength (CIS20-R) in patients with amyotrophic lateral sclerosis - a longitudinal study. Acta Neurol Scand. 2015;131(6):372–380.
   PubMed Web of Science ®Google Scholar
• Lou J-S, Reeves A, Benice T, et al. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60(1):122–123.
   PubMed Web of Science ®Google Scholar
• Morley D, Dummett S, Kelly L, et al. Predictors of activity and participation across neurodegenerative conditions: a comparison of people with motor neurone disease, multiple sclerosis and Parkinson’s disease. BMC Neurol. 2018;18(1):19.
   PubMed Web of Science ®Google Scholar
• Lo Coco D, La Bella V. Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2012;19(5):760–763.
   PubMed Web of Science ®Google Scholar
• Young CA, Ealing J, McDermott C, et al. The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(5–6):317–327.
   PubMed Web of Science ®Google Scholar
• Sharma KR, Kent-Braun JA, Majumdar S, et al. Physiology of fatigue in amyotrophic lateral sclerosis. Neurology. 1995;45(4):733–740.
   PubMed Web of Science ®Google Scholar
• Sanjak M, Brinkmann J, Belden DS, et al. Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis. J Neurol Sci. 2001;191(1–2):55–59.
   PubMed Web of Science ®Google Scholar
• Vucic S, Krishnan AV, Kiernan MC. Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78(11):1202–1208.
   PubMed Web of Science ®Google Scholar
• Abraham A, Drory VE. Fatigue in motor neuron diseases. Neuromuscul Disord. 2012;22(Suppl 3):S198–202.
   PubMed Web of Science ®Google Scholar
• Gibbons CJ, Thornton EW, Young CA. The patient experience of fatigue in motor neurone disease. Front Psychol. 2013;4:788.
   PubMed Web of Science ®Google Scholar
• Vogt S, Schreiber S, Pfau G, et al. Dyspnea as a Fatigue-promoting factor in ALS and the role of objective indicators of respiratory impairment. J Pain Symptom Manage. 2020;60(2):430–438.e1.
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–1123.
   PubMed Web of Science ®Google Scholar
• Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res. 1993;37(7):753–762.
   PubMed Web of Science ®Google Scholar
• Smets EM, Garssen B, Bonke B, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–325.
   PubMed Web of Science ®Google Scholar
• Gibbons CJ, Mills RJ, Thornton EW, et al. Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). Health Qual Life Outcomes. 2011;9:101.
   PubMed Web of Science ®Google Scholar
• Vercoulen JH, Swanink CM, Fennis JF, et al. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383–392.
   PubMed Web of Science ®Google Scholar
• Piper BF, Dibble SL, Dodd MJ, et al. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum. 1998;25(4):677–684.
   PubMedGoogle Scholar
• Adan A, Horne AH. Östberg morningness-eveningness questionnaire: a reduced scale. Pers Individ Dif. 1991;12(3):241–253.
   Web of Science ®Google Scholar
• Roenneberg T, Wirz-Justice A, Merrow M. Life between clocks: daily temporal patterns of human chronotypes. J Biol Rhythms. 2003;18(1):80–90.
   PubMed Web of Science ®Google Scholar
• Sandstedt P, Johansson S, Ytterberg C, et al. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis. J Neurol Sci. 2016;370:269–273.
   PubMed Web of Science ®Google Scholar
• Chio A, Cicolin A., Sleep in ALS: more than discomfort or respiratory breathing disorder. J Neurol Neurosurg Psychiatry. 2020 October 21. jnnp-2020-325002. Published online. DOI:https://doi.org/10.1136/jnnp-2020-325002.
   Google Scholar
• Boentert M. Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives. Nat Sci Sleep. 2019;11:97–111.
   PubMed Web of Science ®Google Scholar
• Lucia D, McCombe PA, Henderson RD, et al. Disorders of sleep and wakefulness in amyotrophic lateral sclerosis (ALS): a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22(3–4):161–169.
   PubMed Web of Science ®Google Scholar
• Reyhani A, Benbir Senel G, Karadeniz D. Effects of sleep-related disorders on the prognosis of amyotrophic lateral sclerosis. Neurodegener Dis. 2019;19(3–4):148–154.
   PubMed Web of Science ®Google Scholar
• Lo Coco D, Puligheddu M, Mattaliano P, et al. REM sleep behavior disorder and periodic leg movements during sleep in ALS. Acta Neurol Scand. 2017;135(2):219–224.
   PubMed Web of Science ®Google Scholar
• Dedeene L, Van Schoor E, Vandenberghe R, et al. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases. Acta Neuropathol Commun. 2019;7(1):189.
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
   PubMed Web of Science ®Google Scholar
• Nishiyama T, Mizuno T, Kojima M, et al. Criterion validity of the Pittsburgh sleep quality index and epworth sleepiness scale for the diagnosis of sleep disorders. Sleep Med. 2014;15(4):422–429.
   PubMed Web of Science ®Google Scholar
• Johns MW. A new method for measuring daytime sleepiness: the epworth sleepiness scale. Sleep. 1991;14(6):540–545.
   PubMed Web of Science ®Google Scholar
• Hoddes E, Dement W, Zarcone V. The development and use of the stanford sleepiness scale. Psychophysiology. 1972;9:150.
   Web of Science ®Google Scholar
• Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res. 2000;48(6):555–560.
   PubMed Web of Science ®Google Scholar
• Bastien CH. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297–307.
   PubMed Web of Science ®Google Scholar
• Fabbri M, Beracci A, Martoni M, et al. Measuring Subjective Sleep Quality: a Review. International Journal of Environmental Research and Public Health. 2021;18(3):1082.
   PubMed Web of Science ®Google Scholar
• Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108(5):812–821.
   PubMed Web of Science ®Google Scholar
• Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131(7):485–491.
   PubMed Web of Science ®Google Scholar
• Chiu H-Y, Chen P-Y, Chuang L-P, et al. Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: a bivariate meta-analysis. Sleep Med Rev. 2017;36:57–70.
   PubMed Web of Science ®Google Scholar
• Helleman J, Kruitwagen-van Reenen ET, Bakers J, et al. Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases. J Neurol. 2020;267(11):3310–3318.
   PubMed Web of Science ®Google Scholar
• Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4(2):97–110.
   PubMedGoogle Scholar
• Walters AS, LeBrocq C, Dhar A, et al. Validation of the International restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121–132.
   PubMed Web of Science ®Google Scholar
• Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394.
   PubMed Web of Science ®Google Scholar
• Stiasny-Kolster K, Mayer G, Schäfer S, et al. The REM sleep behavior disorder screening questionnaire-A new diagnostic instrument. Mov Disord. 2007;22(16):2386–2393.
   PubMed Web of Science ®Google Scholar
• Moglia C, Calvo A, Grassano M, et al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry. 2019;90(6):666–673.
   PubMed Web of Science ®Google Scholar
• Jésus P, Fayemendy P, Nicol M, et al. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25(1):97–104.
   PubMed Web of Science ®Google Scholar
• Steyn FJ, Ioannides ZA, van Eijk RPA, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89(10):1016–1023.
   PubMed Web of Science ®Google Scholar
• Holm T, Maier A, Wicks P, et al. Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study. interactive Journal of Medical Research. 2013;2(1):e8.
   PubMedGoogle Scholar
• Gorges M, Vercruysse P, Müller H-P, et al. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88(12):1033–1041.
   PubMed Web of Science ®Google Scholar
• Bayer D, Antonucci S, Müller H-P, et al. Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients. Transl Neurodegener. 2021;10(1):17.
   PubMed Web of Science ®Google Scholar
• Cykowski MD, Takei H, Schulz PE, et al. TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2014;2(1):171.
   PubMed Web of Science ®Google Scholar
• Vercruysse P, Vieau D, Blum D, et al. Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front Mol Neurosci. 2018;11:2.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Nakayama Y, Matsuda C, et al. Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. J Neurol. 2019;266(6):1412–1420.
   PubMed Web of Science ®Google Scholar
• Wei -Q-Q, Ou R, Cao B, et al. Early weight instability is associated with cognitive decline and poor survival in amyotrophic lateral sclerosis. Brain Res Bull. 2021;171:10–15.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Oudart H, René F, et al. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101(30):11159–11164.
   PubMed Web of Science ®Google Scholar
• Mariosa D, Beard JD, Umbach DM, et al. Body mass index and amyotrophic lateral sclerosis: a study of US Military Veterans. Am J Epidemiol. 2017;185(5):362–371.
   PubMed Web of Science ®Google Scholar
• Zeng P, Yu X, Xu H. Association between premorbid body mass index and amyotrophic lateral sclerosis: causal inference through genetic approaches. Front Neurol. 2019;10:543.
   PubMed Web of Science ®Google Scholar
• Mezoian T, Belt E, Garry J, et al. Loss of appetite in amyotrophic lateral sclerosis is associated with weight loss and decreased calorie consumption independent of dysphagia. Muscle Nerve. 2020;61(2):230–234.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ye S, Chen L, et al. Loss of appetite in patients with amyotrophic lateral sclerosis is associated with weight loss and anxiety/depression. Sci Rep. 2021;11(1):9119.
   PubMed Web of Science ®Google Scholar
• Wilson M-MG, Thomas DR, Rubenstein LZ, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82(5):1074–1081.
   PubMed Web of Science ®Google Scholar
• Ngo ST, van Eijk RPA, Chachay V, et al. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(7–8):497–505.
   PubMed Web of Science ®Google Scholar
• Mathey MF. Assessing appetite in Dutch elderly with the Appetite, Hunger and Sensory Perception (AHSP) questionnaire. J Nutr Health Aging. 2001;5(1):22–28.
   PubMedGoogle Scholar
• Ahmed RM, Irish M, Piguet O, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 2016;15(3):332–342.
   PubMed Web of Science ®Google Scholar
• Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2005;18(5):487–493.
   PubMed Web of Science ®Google Scholar
• Piccione EA, Sletten DM, Staff NP, et al. Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve. 2015;51(5):676–679.
   PubMed Web of Science ®Google Scholar
• Blanc -J-J. Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation? Prog Cardiovasc Dis. 2013;55(4):418–424.
   PubMed Web of Science ®Google Scholar
• Kenny RA, Bayliss J, Ingram A, et al. Head-up tilt: a useful test for investigating unexplained syncope. Lancet. 1986;327(8494):1352–1355.
   Google Scholar
• Pavlovic S, Stevic Z, Milovanovic B, et al. Impairment of cardiac autonomic control in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11(3):272–276.
   PubMed Web of Science ®Google Scholar
• Oey PL, Vos PE, Wieneke GH, et al. Subtle involvement of the sympathetic nervous system in amyotrophic lateral sclerosis. Muscle Nerve. 2002;25(3):402–408.
   PubMed Web of Science ®Google Scholar
• Yamashita A, Koike Y, Takahashi A, et al. Relationship between respiratory failure and plasma noradrenaline levels in amyotrophic lateral sclerosis. Clin Auton Res. 1997;7(4):173–177.
   PubMed Web of Science ®Google Scholar
• Shindo K, Watanabe H, Ohta E, et al. Sympathetic sudomotor neural function in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12(1):39–44.
   PubMed Web of Science ®Google Scholar
• Shindo K, Miwa M, Kobayashi F, et al. Muscle sympathetic nerve activity in frontotemporal lobar degeneration is similar to amyotrophic lateral sclerosis. Clin Auton Res. 2016;26(1):1–5.
   PubMed Web of Science ®Google Scholar
• Asai H, Hirano M, Udaka F, et al. Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS. J Neurol Sci. 2007;254(1–2):78–83.
   PubMed Web of Science ®Google Scholar
• Merico A, Cavinato M. Autonomic dysfunction in the early stage of ALS with bulbar involvement. Amyotroph Lateral Scler. 2011;12(5):363–367.
   PubMed Web of Science ®Google Scholar
• Dalla Vecchia L, De Maria B, Marinou K, et al. Cardiovascular neural regulation is impaired in amyotrophic lateral sclerosis patients. A study by spectral and complexity analysis of cardiovascular oscillations. Physiol Meas. 2015;36(4):659–670.
   PubMed Web of Science ®Google Scholar
• Ono S, Imai T, Takahashi K, et al. Decreased type IV collagen of skin and serum in patients with amyotrophic lateral sclerosis. Neurology. 1998;51(1):114–120.
   PubMed Web of Science ®Google Scholar
• Kolde G, Bachus R, Ludolph AC. Skin involvement in amyotrophic lateral sclerosis. Lancet. 1996;347(9010):1226–1227.
   PubMed Web of Science ®Google Scholar
• Weis J, Katona I, Müller-Newen G, et al. Small-fiber neuropathy in patients with ALS. Neurology. 2011;76(23):2024–2029.
   PubMed Web of Science ®Google Scholar
• Dalla Bella E, Lombardi R, Porretta-Serapiglia C, et al. Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol. 2016;23(2):416–420.
   PubMed Web of Science ®Google Scholar
• Nolano M, Provitera V, Manganelli F, et al. Non-motor involvement in amyotrophic lateral sclerosis: new insight from nerve and vessel analysis in skin biopsy. Neuropathol Appl Neurobiol. 2017;43(2):119–132.
   PubMed Web of Science ®Google Scholar
• Suarez GA, Opfer-Gehrking TL, Offord KP, et al. The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology. 1999;52(3):523–528.
   PubMed Web of Science ®Google Scholar
• Sletten DM, Suarez GA, Low PA, et al. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. 2012;87(12):1196–1201.
   PubMed Web of Science ®Google Scholar
• Figueroa JJ, Dyck PJB, Laughlin RS, et al. Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2012;78(10):702–708.
   PubMed Web of Science ®Google Scholar
• Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc. 1993;68(8):748–752.
   PubMed Web of Science ®Google Scholar
• Bakkers M, Merkies ISJ, Lauria G, et al. Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology. 2009;73(14):1142–1148.
   PubMed Web of Science ®Google Scholar
• Visser M, Marinus J, Stiggelbout AM, et al. Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord. 2004;19(11):1306–1312.
   PubMed Web of Science ®Google Scholar
• Damon-Perrière N, Foubert-Samier A, De Cock VC, et al. Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Parkinsonism Relat Disord. 2012;18(5):612–615.
   PubMed Web of Science ®Google Scholar
• Provitera V, Nolano M, Caporaso G, et al. Postganglionic sudomotor denervation in patients with multiple system atrophy. Neurology. 2014;82(24):2223–2229.
   PubMed Web of Science ®Google Scholar
• Adadan Güvenç I. Sialorrhea: a guide to etiology, assessment, and management. In: Adadan GI, editor. Salivary glands - new approaches in diagnostics and treatment. IntechOpen; 2019 [cited 2021 Jul 25]. Available from: https://www.intechopen.com/chapters/64672 . doi:https://doi.org/10.5772/intechopen.82619
   Google Scholar
• Hockstein NG, Samadi DS, Gendron K, et al. Sialorrhea: a management challenge. Am Fam Physician. 2004;69(11):2628–2634.
   PubMed Web of Science ®Google Scholar
• Garuti G, Rao F, Ribuffo V, et al. Sialorrhea in patients with ALS: current treatment options. Degener Neurol Neuromuscul Dis. 2019;9:19–26.
   PubMed Web of Science ®Google Scholar
• Cazzolli PA, Brooks BR, Nakayama Y, et al. The oral secretion scale and prognostic factors for survival in subjects with amyotrophic lateral sclerosis. Respir Care. 2020;65(8):1063–1076.
   PubMed Web of Science ®Google Scholar
• Hobson EV, McGeachan A, Al-Chalabi A, et al. Management of sialorrhoea in motor neuron disease: a survey of current UK practice. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7–8):521–527.
   PubMed Web of Science ®Google Scholar
• Perez Lloret S, Pirán Arce G, Rossi M, et al. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson’s disease. Mov Disord. 2007;22(1):107–111.
   PubMed Web of Science ®Google Scholar
• Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia. 1988;3(2):73–78.
   PubMedGoogle Scholar
• Reid SM, Johnson HM, Reddihough DS. The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities. Dev Med Child Neurol. 2010;52(2):e23–28.
   PubMed Web of Science ®Google Scholar
• Abdelnour-Mallet M, Tezenas Du Montcel S, Cazzolli PA, et al. Validation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: a study in a large French cohort. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(4):302–307.
   PubMed Web of Science ®Google Scholar
• Yunusova Y, Plowman EK, Green JR, et al. Clinical Measures of Bulbar Dysfunction in ALS. Front Neurol. 2019;10:106.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1–2):13–21.
   PubMed Web of Science ®Google Scholar
• Smith RA, Macklin EA, Myers KJ, et al. Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale). Eur J Neurol. 2018;25(7):907–e66.
   PubMed Web of Science ®Google Scholar
• de Carvalho MLL, Motta R, Battaglia MA, et al. Urinary disorders in amyotrophic lateral sclerosis subjects. Amyotroph Lateral Scler. 2011;12(5):352–355.
   PubMed Web of Science ®Google Scholar
• Nakamura C, Bromberg M, Bhargava S, et al. Mining online social network data for biomedical research: a comparison of clinicians’ and patients’ perceptions about amyotrophic lateral sclerosis treatments. J Med Internet Res. 2012;14(3):e90.
   PubMed Web of Science ®Google Scholar
• Nübling GS, Mie E, Bauer RM, et al. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3–4):174–179.
   PubMed Web of Science ®Google Scholar
• Vázquez-Costa JF, Arlandis S, Hervas D, et al. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder. J Neurol Sci. 2017;378:130–136.
   PubMed Web of Science ®Google Scholar
• Samara VC, Jerant P, Gibson S, et al. Bowel, bladder, and sudomotor symptoms in ALS patients. J Neurol Sci. 2021;427:117543.
   PubMed Web of Science ®Google Scholar
• Kihira T, Yoshida S, Yoshimasu F, et al. Involvement of Onuf’s nucleus in amyotrophic lateral sclerosis. J Neurol Sci. 1997;147(1):81–88.
   PubMed Web of Science ®Google Scholar
• Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–330.
   PubMed Web of Science ®Google Scholar
• Lemack GE, Zimmern PE. Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire. Urology. 1999;54(3):461–466.
   PubMed Web of Science ®Google Scholar
• Jorge MJN, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36(1):77–97.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord. 2007;22(13):1901–1911.
   PubMed Web of Science ®Google Scholar
• Toepfer M. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(1):15–19.
   Google Scholar
• Raheja D, Stephens HE, Lehman E, et al. Patient-reported problematic symptoms in an ALS treatment trial. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3–4):198–205.
   PubMed Web of Science ®Google Scholar
• Desai J, Swash M. Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion. J Neurol Neurosurg Psychiatry. 1999;67(2):214–216.
   PubMed Web of Science ®Google Scholar
• Pradat P-F, Bruneteau G, Munerati E, et al. Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis. Mov Disord. 2009;24(14):2143–2148.
   PubMed Web of Science ®Google Scholar
• Sanjak M, Hirsch MA, Bravver EK, et al. Vestibular deficits leading to disequilibrium and falls in ambulatory amyotrophic lateral sclerosis. Arch Phys Med Rehabil. 2014;95(10):1933–1939.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang S, Huang X, et al. Vestibular evoked myogenic potentials and their clinical utility in patients with amyotrophic lateral sclerosis. Clin Neurophysiol. 2019;130(5):647–654.
   PubMed Web of Science ®Google Scholar
• Jacobs L, Bozian D, Heffner RR, et al. An eye movement disorder in amyotrophic lateral sclerosis. Neurology. 1981;31(10):1282–1287.
   PubMed Web of Science ®Google Scholar
• Shaunak S, Orrell RW, O’Sullivan E, et al. Oculomotor function in amyotrophic lateral sclerosis: evidence for frontal impairment. Ann Neurol. 1995;38(1):38–44.
   PubMed Web of Science ®Google Scholar
• Sharma R, Hicks S, Berna CM, et al. Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Arch Neurol. 2011;68(7):857–861.
   PubMedGoogle Scholar
• Ohki M, Kanayama R, Nakamura T, et al. Ocular abnormalities in amyotrophic lateral sclerosis. Acta Otolaryngol Suppl. 1994;511:138–142.
   PubMedGoogle Scholar
• Donaghy C, Pinnock R, Abrahams S, et al. Slow saccades in bulbar-onset motor neurone disease. J Neurol. 2010;257(7):1134–1140.
   PubMed Web of Science ®Google Scholar
• Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain. 2006;129(Pt 9):2436–2446.
   PubMed Web of Science ®Google Scholar
• Ringelstein M, Albrecht P, Südmeyer M, et al. Subtle retinal pathology in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2014;1(4):290–297.
   PubMed Web of Science ®Google Scholar
• Volpe NJ, Simonett J, Fawzi AA, et al. Ophthalmic manifestations of amyotrophic lateral sclerosis (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc. 2015;113:T12.
   PubMedGoogle Scholar
• Rojas P, de Hoz R, Ramírez AI, et al. Changes in RETINAL OCT and their correlations with neurological disability in early ALS patients, a follow-up study. Brain Sci. 2019;9(12):E337.
   PubMed Web of Science ®Google Scholar
• Vasta R, Moglia C, D’Ovidio F, et al. Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22(3–4):308–311.
   PubMed Web of Science ®Google Scholar
• Howard IM, Burgess K. Telehealth for Amyotrophic Lateral Sclerosis and Multiple Sclerosis. Phys Med Rehabil Clin N Am. 2021;32(2):239–251.
   PubMed Web of Science ®Google Scholar
• Montes J, Levy G, Albert S, et al. Development and evaluation of a self-administered version of the ALSFRS-R. Neurology. 2006;67(7):1294–1296.
   PubMed Web of Science ®Google Scholar
• Berry JD, Paganoni S, Carlson K, et al. Design and results of a smartphone-based digital phenotyping study to quantify ALS progression. Ann Clin Transl Neurol. 2019;6(5):873–881.
   PubMed Web of Science ®Google Scholar
• Hernandez-Ramos R, Aguilera A, Garcia F, et al. Conducting internet-based visits for onboarding populations with limited digital literacy to an mhealth intervention: development of a patient-centered approach. JMIR Form Res. 2021;5(4):e25299.
   PubMedGoogle Scholar